Human-derived acellular matrices for dermal replacement - Biomaterials for Treating Skin Loss - page 172

'Dynamics of basement membrane formation by keratinocyte-fibroblast interactions in
organotypic skin culture', Exp Cell Res , 239 (2), 399-410.
Tarnuzzer, R. W. and Schultz, G. S. (1996), 'Biochemical analysis of acute and chronic
wound environments', Wound Repair Regen , 4 (3), 321-5.
Trengove, N. J., Stacey, M. C., MacAuley, S., Bennett, N., Gibson, J., Burslem, F., Murphy,
G. and Schultz, G. (1999), 'Analysis of the acute and chronic wound environments: the
role of proteases and their inhibitors', Wound Repair Regen , 7 (6), 442-52.
Trengove, N. J., Bielefeldt-Ohmann, H. and Stacey, M. C. (2000), 'Mitogenic activity and
cytokine levels in non-healing and healing chronic leg ulcers', Wound Repair Regen , 8 (1),
13-25.
Tsai, C. C., Lin, S. D., Lai, C. S. and Lin, T. M. (1999), 'The use of composite acellular
allodermis-ultrathin autograft on joint area in major burn patients - one year follow-up',
Kaohsiung J Med Sci , 15 (11), 651-8.
Tufvesson, E. and Westergren-Thorsson, G. (2002), 'Tumour necrosis factor-alpha interacts
with biglycan and decorin', FEBS Lett , 530 (1-3), 124-8.
Valentin, J. E., Badylak, J. S., McCabe, G. P. and Badylak, S. F. (2006), 'Extracellular matrix
bioscaffolds for orthopaedic applications. A comparative histologic study', J Bone Joint
Surg Am , 88 (12), 2673-86.
Wainwright, D. J. (1995), 'Use of an acellular allograft dermal matrix (AlloDerm) in the
management of full-thickness burns', Burns , 21 (4), 243-8.
Wainwright, D., Madden, M., Luterman, A., Hunt, J., Monafo, W., Heimbach, D., Kagan, R.,
Sittig, K., Dimick, A. and Herndon, D. (1996), 'Clinical evaluation of an acellular allograft
dermal matrix in full-thickness burns', J Burn Care Rehabil , 17 (2), 124-36.
Werner, S. and Grose, R. (2003), 'Regulation of wound healing by growth factors and
cytokines', Physiol Rev , 83 (3), 835-70.
Wollina, U., Berger, U. and Mahrle, G. (1991), 'Immunohistochemistry of porcine skin',
Acta Histochem , 90 (1), 87-91.
Xue, M., Le, N. T. and Jackson, C. J. (2006), 'Targeting matrix metalloproteases to improve
cutaneous wound healing', Expert Opin Ther Targets , 10 (1), 143-55.
Yamaguchi, Y., Mann, D. M. and Ruoslahti, E. (1990), 'Negative regulation of transforming
growth factor-beta by the proteoglycan decorin', Nature , 346 (6281), 281-4.
Young, M. F., Bi, Y., Ameye, L. and Chen, X. D. (2002), 'Biglycan knockout mice: new
models for musculoskeletal diseases', Glycoconj J , 19 (4-5), 257-62.
Zienowicz, R. J. and Karacaoglu, E. (2007), 'Implant-based breast reconstruction with
allograft', Plast Reconstr Surg , 120 (2), 373-81.
10.9 Disclosure
The authors are employees and stockholders of LifeCell Corporation, manufac-
turer of the acellular regenerative tissue matrix products discussed herein.